Unknown

Dataset Information

0

Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Bezerra MF 

PROVIDER: S-EPMC5286952 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
| S-EPMC4823650 | biostudies-literature
Unknown Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
| S-EPMC4603608 | biostudies-literature
Unknown Association between <i>TP53</i> gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population.
| S-EPMC5328300 | biostudies-literature
Unknown The TP53 Arg72Pro polymorphism predicts visual and neurodegenerative outcomes in retinal detachment.
| S-EPMC12106684 | biostudies-literature
Unknown Association Between Arg72Pro Polymorphism in <i>TP53</i> and Malignant Abdominal Solid Tumor Risk in Hunan Children.
| S-EPMC8204553 | biostudies-literature
Unknown The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
| S-EPMC5352043 | biostudies-literature
Unknown Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax.
| S-EPMC10462434 | biostudies-literature
Unknown Targeting <i>TP53</i>-Mutated Acute Myeloid Leukemia: Research and Clinical Developments.
| S-EPMC9037178 | biostudies-literature
Unknown Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.
| S-EPMC4621257 | biostudies-literature
Unknown Targeting acute myeloid leukemia with TP53-independent vosaroxin.
| S-EPMC5144553 | biostudies-literature